Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Amgen options imply 3.2% move in share price post-earnings » 14:04
01/31/23
01/31
14:04
01/31/23
14:04
AMGN

Amgen

$251.40 /

-0.17 (-0.07%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$251.40 /

-0.17 (-0.07%)

AMGN Amgen
$251.40 /

-0.17 (-0.07%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/03/23 Barclays
Research raises 'valid questions' about Amgen's Repatha, says Barclays
12/13/22 BMO Capital
Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital
12/13/22 Baird
Amgen deal yields nice accretion but large debt position, says Baird
AMGN Amgen
$251.40 /

-0.17 (-0.07%)

AMGN Amgen
$251.40 /

-0.17 (-0.07%)

AMGN Amgen
$251.40 /

-0.17 (-0.07%)

AMGN Amgen
$251.40 /

-0.17 (-0.07%)

Recommendations
Workday focus on 'efficient growth is prudent,' says Jefferies » 14:03
01/31/23
01/31
14:03
01/31/23
14:03
WDAY

Workday

$178.69 /

+1.91 (+1.08%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WDAY Workday
$178.69 /

+1.91 (+1.08%)

WDAY Workday
$178.69 /

+1.91 (+1.08%)

01/23/23 Deutsche Bank
Workday downgraded to Hold from Buy at Deutsche Bank
01/17/23 Guggenheim
Workday downgraded to Sell from Neutral at Guggenheim
01/13/23 Capital One
Workday initiated with an Overweight at Capital One
01/09/23 MoffettNathanson
Workday initiated with an Outperform at MoffettNathanson
WDAY Workday
$178.69 /

+1.91 (+1.08%)

WDAY Workday
$178.69 /

+1.91 (+1.08%)

WDAY Workday
$178.69 /

+1.91 (+1.08%)

WDAY Workday
$178.69 /

+1.91 (+1.08%)

Hot Stocks
Workday to eliminate about 3% of global workforce in realignment » 14:02
01/31/23
01/31
14:02
01/31/23
14:02
WDAY

Workday

$178.30 /

+1.52 (+0.86%)

In a regulatory filing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WDAY Workday
$178.30 /

+1.52 (+0.86%)

WDAY Workday
$178.30 /

+1.52 (+0.86%)

01/23/23 Deutsche Bank
Workday downgraded to Hold from Buy at Deutsche Bank
01/17/23 Guggenheim
Workday downgraded to Sell from Neutral at Guggenheim
01/13/23 Capital One
Workday initiated with an Overweight at Capital One
01/09/23 MoffettNathanson
Workday initiated with an Outperform at MoffettNathanson
WDAY Workday
$178.30 /

+1.52 (+0.86%)

WDAY Workday
$178.30 /

+1.52 (+0.86%)

WDAY Workday
$178.30 /

+1.52 (+0.86%)

WDAY Workday
$178.30 /

+1.52 (+0.86%)

Earnings
Notable companies reporting after market close » 13:20
01/31/23
01/31
13:20
01/31/23
13:20
AMGN

Amgen

$250.97 /

-0.6 (-0.24%)

, AMD

AMD

$74.25 /

+1.82 (+2.51%)

, MDLZ

Mondelez

$65.07 /

+0.21 (+0.32%)

, EW

Edwards Lifesciences

$75.64 /

-0.485 (-0.64%)

, EA

Electronic Arts

$129.13 /

+0.1 (+0.08%)

, SNAP

Snap

$11.45 /

+0.32 (+2.88%)

, MTCH

Match Group

$54.34 /

+1.96 (+3.74%)

, WDC

Western Digital

$43.55 /

-0.695 (-1.57%)

, JNPR

Juniper

$31.83 /

-0.295 (-0.92%)

Notable companies…

Notable companies reporting after the market close, with earnings consensus, include Amgen (AMGN), consensus $4.09... AMD (AMD), consensus 67c... Mondelez (MDLZ), consensus 70c... Edward Lifesciences (EW), consensus 61c... Electronic Arts (EA), consensus $3.05... Snap (SNAP), consensus 11c... Match Group (MTCH), consensus 46c... Western Digital (WDC), consensus (12c)... Juniper Networks (JNPR), consensus 65c.

ShowHide Related Items >><<
AMGN Amgen
$250.97 /

-0.6 (-0.24%)

AMD AMD
$74.25 /

+1.82 (+2.51%)

MDLZ Mondelez
$65.07 /

+0.21 (+0.32%)

EW Edwards Lifesciences
$75.64 /

-0.485 (-0.64%)

EA Electronic Arts
$129.13 /

+0.1 (+0.08%)

SNAP Snap
$11.45 /

+0.32 (+2.88%)

MTCH Match Group
$54.34 /

+1.96 (+3.74%)

WDC Western Digital
$43.55 /

-0.695 (-1.57%)

JNPR Juniper
$31.83 /

-0.295 (-0.92%)

AMGN Amgen
$250.97 /

-0.6 (-0.24%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/03/23 Barclays
Research raises 'valid questions' about Amgen's Repatha, says Barclays
12/13/22 BMO Capital
Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital
12/13/22 Baird
Amgen deal yields nice accretion but large debt position, says Baird
AMD AMD
$74.25 /

+1.82 (+2.51%)

01/30/23 Morgan Stanley
Intel's quarter points to some risk for AMD in Q1, says Morgan Stanley
01/30/23 Susquehanna
AMD price target raised to $88 from $80 at Susquehanna
01/27/23 BofA
Intel price target lowered to $25 from $28 at BofA
01/27/23 Barclays
Intel price target lowered to $27 from $30 at Barclays
MDLZ Mondelez
$65.07 /

+0.21 (+0.32%)

01/06/23 Mizuho
Mondelez price target raised to $78 from $75 at Mizuho
01/03/23 Wells Fargo
Mondelez initiated with an Overweight at Wells Fargo
01/03/23 RBC Capital
Mondelez downgraded to Sector Perform from Outperform at RBC Capital
12/20/22 Morgan Stanley
Mondelez price target raised to $75 from $69 at Morgan Stanley
EW Edwards Lifesciences
$75.64 /

-0.485 (-0.64%)

07:37 Today Bernstein
Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein
01/30/23 Piper Sandler
Edwards Lifesciences downgraded to Neutral from Overweight at Piper Sandler
12/12/22 Canaccord
Edwards Lifesciences price target lowered to $73 from $78 at Canaccord
12/12/22 Citi
Edwards Lifesciences price target lowered to $92 from $99 at Citi
EA Electronic Arts
$129.13 /

+0.1 (+0.08%)

01/27/23 Wedbush
Electronic Arts initiated with an Outperform at Wedbush
01/27/23 Credit Suisse
Electronic Arts price target raised to $154 from $143 at Credit Suisse
01/25/23 Barclays
Electronic Arts price target raised to $132 from $130 at Barclays
01/17/23 Benchmark
Electronic Arts price target lowered to $150 from $188 at Benchmark
SNAP Snap
$11.45 /

+0.32 (+2.88%)

01/20/23 MKM Partners
MKM Partners cuts Pinterest to Neutral, sees balanced risk-reward
01/19/23 JPMorgan
JPMorgan calls out Meta as top pick ahead of earnings from online ads group
01/18/23 OTR Global
Snap downgraded to Mixed from Positive view at OTR Global
01/17/23 JMP Securities
Snap downgraded to Market Perform from Outperform at JMP Securities
MTCH Match Group
$54.34 /

+1.96 (+3.74%)

01/30/23 Deutsche Bank
Match Group price target raised to $65 from $60 at Deutsche Bank
01/26/23 Citi
Match Group initiated with a Neutral at Citi
01/25/23 Barclays
Match Group price target raised to $52 from $50 at Barclays
01/24/23 Jefferies
Match Group, Bumble price targets raised at Jefferies ahead of earnings
WDC Western Digital
$43.55 /

-0.695 (-1.57%)

01/23/23 Exane BNP Paribas
Western Digital upgraded to Neutral from Underperform at Exane BNP Paribas
01/06/23 Benchmark
Western Digital upgraded to Hold at Benchmark after Kioxia merger talks report
01/06/23 Benchmark
Western Digital upgraded to Hold from Sell at Benchmark
01/05/23 Deutsche Bank
Western Digital, Kioxia deal makes 'a lot of sense,' says Deutsche Bank
JNPR Juniper
$31.83 /

-0.295 (-0.92%)

01/17/23 Piper Sandler
Juniper price target raised to $32 from $31 at Piper Sandler
12/20/22 JPMorgan
JPMorgan ups Juniper target, adds to Analyst Focus List
12/13/22 Morgan Stanley
Juniper price target raised to $29 from $25 at Morgan Stanley
10/26/22 Piper Sandler
Juniper price target raised to $31 from $29 at Piper Sandler
AMGN Amgen
$250.97 /

-0.6 (-0.24%)

AMD AMD
$74.25 /

+1.82 (+2.51%)

MDLZ Mondelez
$65.07 /

+0.21 (+0.32%)

EW Edwards Lifesciences
$75.64 /

-0.485 (-0.64%)

EA Electronic Arts
$129.13 /

+0.1 (+0.08%)

SNAP Snap
$11.45 /

+0.32 (+2.88%)

MTCH Match Group
$54.34 /

+1.96 (+3.74%)

WDC Western Digital
$43.55 /

-0.695 (-1.57%)

JNPR Juniper
$31.83 /

-0.295 (-0.92%)

AMGN Amgen
$250.97 /

-0.6 (-0.24%)

AMD AMD
$74.25 /

+1.82 (+2.51%)

MDLZ Mondelez
$65.07 /

+0.21 (+0.32%)

EA Electronic Arts
$129.13 /

+0.1 (+0.08%)

SNAP Snap
$11.45 /

+0.32 (+2.88%)

MTCH Match Group
$54.34 /

+1.96 (+3.74%)

WDC Western Digital
$43.55 /

-0.695 (-1.57%)

JNPR Juniper
$31.83 /

-0.295 (-0.92%)

AMGN Amgen
$250.97 /

-0.6 (-0.24%)

AMD AMD
$74.25 /

+1.82 (+2.51%)

MDLZ Mondelez
$65.07 /

+0.21 (+0.32%)

EW Edwards Lifesciences
$75.64 /

-0.485 (-0.64%)

EA Electronic Arts
$129.13 /

+0.1 (+0.08%)

SNAP Snap
$11.45 /

+0.32 (+2.88%)

MTCH Match Group
$54.34 /

+1.96 (+3.74%)

WDC Western Digital
$43.55 /

-0.695 (-1.57%)

JNPR Juniper
$31.83 /

-0.295 (-0.92%)

AMGN Amgen
$250.97 /

-0.6 (-0.24%)

AMD AMD
$74.25 /

+1.82 (+2.51%)

MDLZ Mondelez
$65.07 /

+0.21 (+0.32%)

EW Edwards Lifesciences
$75.64 /

-0.485 (-0.64%)

EA Electronic Arts
$129.13 /

+0.1 (+0.08%)

SNAP Snap
$11.45 /

+0.32 (+2.88%)

MTCH Match Group
$54.34 /

+1.96 (+3.74%)

WDC Western Digital
$43.55 /

-0.695 (-1.57%)

Recommendations
Sanofi price target raised to EUR 100 from EUR 91 at Berenberg » 13:14
01/31/23
01/31
13:14
01/31/23
13:14
SNY

Sanofi

$48.81 /

+0.22 (+0.45%)

Berenberg analyst Luisa…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$48.81 /

+0.22 (+0.45%)

SNY Sanofi
$48.81 /

+0.22 (+0.45%)

12/21/22 Barclays
Sanofi, Pfizer settled first California Zantac bellwether case, says Barclays
12/16/22 Goldman Sachs
Sanofi reinstated with a Buy at Goldman Sachs
12/15/22 Guggenheim
Vaxcyte initiated with a Buy at Guggenheim on pneumococcal vaccine potential
12/14/22 UBS
Sanofi price target raised to EUR 97 from EUR 92 at UBS
SNY Sanofi
$48.81 /

+0.22 (+0.45%)

SNY Sanofi
$48.81 /

+0.22 (+0.45%)

SNY Sanofi
$48.81 /

+0.22 (+0.45%)

SNY Sanofi
$48.81 /

+0.22 (+0.45%)

Recommendations
Wells sees J&J talc settlement reaching a 'manageable' $10B » 09:31
01/31/23
01/31
09:31
01/31/23
09:31
JNJ

Johnson & Johnson

$162.00 /

-6.19 (-3.68%)

Wells Fargo analyst Larry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

08:18 Today BofA
J&J talc bankruptcy case dismissal impact to be determined, says BofA
01/27/23 BTIG
BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal
01/27/23 Piper Sandler
Piper keeps $78 target on Legend Biotech after Carvykti trial hits
01/25/23 JMP Securities
J&J conference call comments 'a good sign' for Protagonist, says JMP Securities
JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

Recommendations
J&J talc bankruptcy case dismissal impact to be determined, says BofA » 08:18
01/31/23
01/31
08:18
01/31/23
08:18
JNJ

Johnson & Johnson

$162.00 /

-6.19 (-3.68%)

After the Third U.S.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

01/27/23 BTIG
BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal
01/27/23 Piper Sandler
Piper keeps $78 target on Legend Biotech after Carvykti trial hits
01/25/23 JMP Securities
J&J conference call comments 'a good sign' for Protagonist, says JMP Securities
01/24/23 H.C. Wainwright
Fate Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

Options
Johnson & Johnson put buyer realizes 135% same-day gains » 08:00
01/31/23
01/31
08:00
01/31/23
08:00
JNJ

Johnson & Johnson

$162.00 /

-6.19 (-3.68%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

01/27/23 BTIG
BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal
01/27/23 Piper Sandler
Piper keeps $78 target on Legend Biotech after Carvykti trial hits
01/25/23 JMP Securities
J&J conference call comments 'a good sign' for Protagonist, says JMP Securities
01/24/23 H.C. Wainwright
Fate Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

JNJ Johnson & Johnson
$162.00 /

-6.19 (-3.68%)

Periodicals
AbbVie's Humira drug faces competition in the U.S., FT reports » 06:26
01/31/23
01/31
06:26
01/31/23
06:26
ABBV

AbbVie

$145.64 /

-0.6 (-0.41%)

, AMGN

Amgen

$251.57 /

-2.06 (-0.81%)

AbbVie (ABBV) has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$251.57 /

-2.06 (-0.81%)

ABBV AbbVie
$145.64 /

-0.6 (-0.41%)

ABBV AbbVie
$145.64 /

-0.6 (-0.41%)

01/26/23 JPMorgan
AbbVie recent weakness a buying opportunity, says JPMorgan
01/05/23 Truist
AbbVie price target raised to $180 from $160 at Truist
11/17/22 Credit Suisse
AbbVie initiated with an Outperform at Credit Suisse
11/08/22 Societe Generale
AbbVie downgraded at Societe Generale on blood cancer and aesthetics headwinds
AMGN Amgen
$251.57 /

-2.06 (-0.81%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/03/23 Barclays
Research raises 'valid questions' about Amgen's Repatha, says Barclays
12/13/22 BMO Capital
Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital
12/13/22 Baird
Amgen deal yields nice accretion but large debt position, says Baird
AMGN Amgen
$251.57 /

-2.06 (-0.81%)

ABBV AbbVie
$145.64 /

-0.6 (-0.41%)

AMGN Amgen
$251.57 /

-2.06 (-0.81%)

ABBV AbbVie
$145.64 /

-0.6 (-0.41%)

AMGN Amgen
$251.57 /

-2.06 (-0.81%)

ABBV AbbVie
$145.64 /

-0.6 (-0.41%)

AMGN Amgen
$251.57 /

-2.06 (-0.81%)

ABBV AbbVie
$145.64 /

-0.6 (-0.41%)

Hot Stocks
Amgen announces Humira biosimilar now available in the U.S. » 06:18
01/31/23
01/31
06:18
01/31/23
06:18
AMGN

Amgen

$251.57 /

-2.06 (-0.81%)

Amgen announced Amjevita,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$251.57 /

-2.06 (-0.81%)

AMGN Amgen
$251.57 /

-2.06 (-0.81%)

01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/03/23 Barclays
Research raises 'valid questions' about Amgen's Repatha, says Barclays
12/13/22 BMO Capital
Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital
12/13/22 Baird
Amgen deal yields nice accretion but large debt position, says Baird
AMGN Amgen
$251.57 /

-2.06 (-0.81%)

AMGN Amgen
$251.57 /

-2.06 (-0.81%)

AMGN Amgen
$251.57 /

-2.06 (-0.81%)

AMGN Amgen
$251.57 /

-2.06 (-0.81%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.